Literature DB >> 31813630

The impact of Candida spp airway colonization on clinical outcomes in patients with ventilator-associated pneumonia: A systematic review and meta-analysis.

Dong Huang1, Min Qi1, Yuehong Hu1, Mingjing Yu1, Zongan Liang2.   

Abstract

BACKGROUND: Previous studies have drawn different conclusions about the impact of Candida airway colonization on clinical outcomes in patients with ventilator-associated pneumonia (VAP).
METHODS: We searched PubMed, the Cochrane Library, Embase (via OVID), and Web of Science database. We included both retrospective and prospective observational studies. The mean difference (MD) or risk ratio (RR) with 95% confidence intervals (CI) were applied to assess the association between Candida colonization and clinical outcomes.
RESULTS: A total of 8 studies with 1,661 patients were pooled in our final studies. Compared with patients with VAP without Candida colonization, patients with Candida colonization had significantly longer durations of mechanical ventilation (MD, 1.93; 95% CI, 0.53-3.33). The intensive care unit (ICU) length of stay seems to be longer among Candida colonized patients than noncolonized patients, although the results were not so significant (MD, 1.15; 95% CI, -1.04 to 3.34). Patients with colonization had higher 28-day mortality and ICU mortality than those without colonization (28-day mortality: RR, 1.64; 95% CI, 1.27-2.12; ICU mortality: RR, 1.57; 95% CI, 1.26-1.94).
CONCLUSIONS: The presence of Candida spp airway colonization is associated with longer durations of mechanical ventilation, higher 28-day mortality, higher ICU mortality, and probably longer ICU length of stay compared with the absence of colonization in patients with VAP.
Copyright © 2019 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Critical care

Mesh:

Year:  2019        PMID: 31813630     DOI: 10.1016/j.ajic.2019.11.002

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  5 in total

1.  Candida spp. isolation from critically ill patients' respiratory tract. Does antifungal treatment affect survival?

Authors:  Petros Ioannou; Alexandra Vouidaski; Nikolaos Spernovasilis; Christina Alexopoulou; Andria Papazachariou; Eleni Paraschou; Aikaterini Achyropoulou; Sofia Maraki; George Samonis; Diamantis P Kofteridis
Journal:  Germs       Date:  2021-12-29

Review 2.  Diagnostic and therapeutic approach to fungal pneumonia in the critically ill patient.

Authors:  J Fortún
Journal:  Rev Esp Quimioter       Date:  2022-04-22       Impact factor: 2.515

3.  Candida and the Gram-positive trio: testing the vibe in the ICU patient microbiome using structural equation modelling of literature derived data.

Authors:  James C Hurley
Journal:  Emerg Themes Epidemiol       Date:  2022-08-18

4.  Candida-Acinetobacter-Pseudomonas Interaction Modelled within 286 ICU Infection Prevention Studies.

Authors:  James C Hurley
Journal:  J Fungi (Basel)       Date:  2020-10-27

5.  Structural equation modelling the relationship between anti-fungal prophylaxis and Pseudomonas bacteremia in ICU patients.

Authors:  James C Hurley
Journal:  Intensive Care Med Exp       Date:  2022-01-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.